XML 77 R31.htm IDEA: XBRL DOCUMENT v3.19.3
EPS Calculation (Tables)
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS
The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and nine months ended September 30, 2019 and 2018:
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(In Thousands, Except Per Share Amounts)
 
2019
 
2018
 
2019
 
2018
Basic EPS:
 
 
 
 
 
 
 
 
Net income to common stockholders
 
$
95,599

 
$
87,132

 
$
277,496

 
$
240,922

Dividends declared on preferred stock
 
(3,750
)
 
(3,750
)
 
(11,250
)
 
(11,250
)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities
 
(280
)
 
(241
)
 
(808
)
 
(702
)
Net income to common stockholders - basic
 
$
91,569

 
$
83,141

 
$
265,438

 
$
228,970

Basic weighted average common shares outstanding
 
451,020

 
428,713

 
450,641

 
408,614

Basic EPS
 
$
0.20

 
$
0.19

 
$
0.59

 
$
0.56

 
 
 
 
 
 
 
 
 
Diluted EPS:
 
 
 
 
 
 
 
 
Net income to common stockholders - basic
 
91,569

 
83,141

 
265,438

 
228,970

Interest expense on Convertible Senior Notes
 
3,879

 

 
5,085

 

Net income to common stockholders - diluted
 
$
95,448

 
$
83,141

 
$
270,523

 
$
228,970

Basic weighted average common shares outstanding
 
451,020

 
428,713

 
450,641

 
408,614

Effect of assumed Convertible Senior Notes conversion to common shares
 
28,920

 

 
12,712

 

Diluted weighted average common shares outstanding (1)
 
479,940

 
428,713

 
463,353

 
408,614

Diluted EPS
 
$
0.20

 
$
0.19

 
$
0.58

 
$
0.56



(1)
At September 30, 2019, the Company had approximately 3.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2019, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $7.37. These equity instruments may have a dilutive impact on future EPS.  

During the three and nine months ended September 30, 2019, the Convertible Senior Notes were determined to be dilutive and were included in the calculation of diluted EPS under the “if-converted” method. Under this method, the periodic interest expense for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether the conversion option is in or out of the money) is included in the denominator for the purpose of calculating diluted EPS.